Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 24.

Zweifel, S A; Tönz, M S; Pfenninger, L; Becker, M; Michels, S (2013). Intravitreal anti-VEGF therapy for retinal macroaneurysm. Klinische Monatsblätter für Augenheilkunde, 230(4):392-395.

Winnik, S; Lohmann, C; Siciliani, G; von Lukowicz, T; Kuschnerus, K; Kraenkel, N; Brokopp, C E; Enseleit, F; Michels, S; Ruschitzka, F; Luscher, T F; Matter, C M (2013). Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis - implications for cardiovascular safety. International Journal of Cardiology, 168(3):2453-2461.

Michels, R; Michels, S; Kaminski, S (2012). Effect of combined topical heparin and steroid on corneal neovascularization in children. Ophthalmic Surgery, Lasers & Imaging, 43(6):452-458.

Zweifel, S A; Maygar, I; Berger, W; Tschuor, P; Becker, M; Michels, S (2012). Multimodal imaging of autosomal dominant drusen. Klinische Monatsblätter für Augenheilkunde, 229(4):399-402.

Kloeckener-Gruissem, B; Barthelmes, D; Labs, S; Schindler, C; Kurz-Levin, M; Michels, S; Fleischhauer, J; Berger, W; Sutter, F; Menghini, M (2011). Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD. Investigative Ophthalmology and Visual Science, 52(7):4694-4702.

Knecht, P B; Bosch, M M; Michels, S; Mannhardt, S; Schmid, U; Bosch, M A; Menke, M N (2011). The ocular pulse amplitude at different intraocular pressure: a prospective study. Acta Ophthalmologica, 89(5):e466-e471.

Menghini, M; Kurz-Levin, M M; Amstutz, C; Michels, S; Windisch, R; Barthelmes, D; Sutter, F K P (2010). Response to ranibizumab therapy in neovascular AMD - an evaluation of good and bad responders. Klinische Monatsblätter für Augenheilkunde, 227(4):244-248.

Enseleit, F; Michels, S; Ruschitzka, F (2010). Anti-VEGF therapies and blood pressure: more than meets the eye. Current Hypertension Reports, 12(1):33-38.

Sacu, S; Stifter, E; Vécsei-Marlovits, P V; Michels, S; Schütze, C; Prünte, C; Schmidt-Erfurth, U (2009). Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration. Eye, 23(6):1404-1410.

Lalwani, G A; Rosenfeld, P J; Fung, A E; Dubovy, S R; Michels, S; Feuer, W; Davis, J L; Flynn, H W Jr; Esquiabro, M (2009). A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. American Journal of Ophthalmology, 148(1):43-58.

Michels, S; Kurz-Levin, M (2009). Altersbezogene Makuladegeneration (AMD). Therapeutische Umschau, 66(3):189-195.

Boothe, B (2009). Editorial. In: Grimm, G; Kapfhamer, N; Mathys, H; Michels, S; Boothe, B. Erzählen, Träumen, Erinnern. Lengerich, DE: Pabst, 101-109.

Sacu, S; Michels, S; Prager, F; Weigert, G; Dunavoelgyi, R; Geitzenauer, W; Pruente, C; Schmidt-Erfurth, U (2009). Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term results. Eye, 23(12):2223-2227.

Knecht, P B; Michels, S; Sturm, V; Bosch, M M; Menke, M N (2009). Tunnelled versus straight intravitreal injection: intraocular pressure changes, vitreous reflux, and patient discomfort. Retina, 29(8):1175-1181.

Prager, F; Michels, S; Simader, C; Geitzenauer, W; Schmidt-Erfurth, U (2008). Changes in retinal sensitivity in patients with neovascular age-related macular degeneration after systemic bevacizumab (avastin) therapy. Retina, 28(5):682-688.

Weigert, G; Michels, S; Sacu, S; Varga, A; Prager, F; Geitzenauer, W; Schmidt-Erfurth, U (2008). Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study. British Journal of Ophthalmology, 92(3):356-360.

Kiss, C G; Simader, C; Michels, S; Schmidt-Erfurth, U (2008). Combination of verteporfin photodynamic therapy and ranibizumab: effects on retinal anatomy, choroidal perfusion and visual function in the protect study. British Journal of Ophthalmology, 92(12):1620-1627.

Geitzenauer, W; Michels, S; Prager, F; Rosenfeld, P J; Kornek, G; Vormittag, L; Schmidt-Erfurth, U (2008). Comparison of 2.5 mg/kg and 5 mg/kg systemic bevacizumab in neovascular age-related macular degeneration: twenty-four week results of an uncontrolled, prospective cohort study. Retina, 28(10):1375-1386.

Michels, S. Fortschritte in der medikamentösen Behandlung der neovaskulären, altersbezogenen Makuladegeneration. 2008, University of Zurich, Faculty of Medicine.

Kriechbaum, K; Michels, S; Prager, F; Georgopoulos, M; Funk, M; Geitzenauer, W; Schmidt-Erfurth, U (2008). Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. British Journal of Ophthalmology, 92(4):518-522.

Michels, S; Messmer, E; Sutter, F; Kurz-Levin, M M (2008). Intravitreale anti-VEGF-Therapie von retinalen kapillären Hämangioblastomen bei von-Hippel-Lindau-Erkrankung. Klinische Monatsblätter für Augenheilkunde, 225(4):292-294.

Sacu, S; Varga, A; Michels, S; Weigert, G; Polak, K; Vécsei-Marlovits, P V; Schmidt-Erfurth, U (2008). Reduced fluence versus standard photodynamic therapy in combination with intravitreal triamcinolone: short-term results of a randomised study. British Journal of Ophthalmology, 92(10):1347-1351.

Götzinger, E; Pircher, M; Geitzenauer, W; Ahlers, C; Baumann, B; Michels, S; Schmidt-Erfurth, U; Hitzenberger, C K (2008). Retinal pigment epithelium segmentation by polarization sensitive optical coherence tomography. Optics Express, 16(21):16410-16422.

Michels, S; Pircher, M; Geitzenauer, W; Simader, C; Götzinger, E; Findl, O; Schmidt-Erfurth, U; Hitzenberger, C K (2008). Value of polarisation-sensitive optical coherence tomography in diseases affecting the retinal pigment epithelium. British Journal of Ophthalmology, 92(2):204-209.

This list was generated on Fri Sep 22 13:59:36 2017 CEST.